These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1830125)
1. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association. Simon P; Charpentier S; Costentin J Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):99-104. PubMed ID: 1830125 [TBL] [Abstract][Full Text] [Related]
3. [The effect of dopamine receptor stimulation on the motor and stereotypic activities of mice with different genotypes]. Skrinskaia IuA; Nikulina EM Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):549-55. PubMed ID: 1353935 [TBL] [Abstract][Full Text] [Related]
4. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349 [TBL] [Abstract][Full Text] [Related]
5. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors. Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422 [TBL] [Abstract][Full Text] [Related]
6. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist. Bartoszyk GD; Harting J; Minck KO J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454 [TBL] [Abstract][Full Text] [Related]
7. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists. Berridge KC; Aldridge JW Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041 [TBL] [Abstract][Full Text] [Related]
8. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Neal-Beliveau BS; Joyce JN Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220 [TBL] [Abstract][Full Text] [Related]
9. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice. Verma A; Kulkarni SK Indian J Exp Biol; 1991 Feb; 29(2):123-6. PubMed ID: 1831182 [TBL] [Abstract][Full Text] [Related]
10. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. Hess EJ; Albers LJ; Le H; Creese I J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223 [TBL] [Abstract][Full Text] [Related]
11. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
12. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine. Zhang SP; Zhou LW; Weiss B J Pharmacol Exp Ther; 1994 Dec; 271(3):1462-70. PubMed ID: 7996459 [TBL] [Abstract][Full Text] [Related]
13. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates. Byrnes EM; Bruno JP Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729 [TBL] [Abstract][Full Text] [Related]
14. Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: assessment of the role of D1 dopamine receptor stimulation. Rowlett JK; Mattingly BA; Bardo MT Synapse; 1993 Jun; 14(2):160-8. PubMed ID: 8332946 [TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors. Ichihara K; Nabeshima T; Kameyama T Eur J Pharmacol; 1992 Mar; 213(2):243-9. PubMed ID: 1355736 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor "knockout". McNamara FN; Clifford JJ; Tighe O; Kinsella A; Drago J; Fuchs S; Croke DT; Waddington JL Synapse; 2002 Oct; 46(1):19-31. PubMed ID: 12211095 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys. Bergman J; Rosenzweig-Lipson S; Spealman RD J Pharmacol Exp Ther; 1995 Apr; 273(1):40-8. PubMed ID: 7714795 [TBL] [Abstract][Full Text] [Related]
18. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213. Meller E; Bordi F; Bohmaker K Life Sci; 1988; 42(25):2561-7. PubMed ID: 3260320 [TBL] [Abstract][Full Text] [Related]
19. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens. Rouillon C; Abraini JH; David HN Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350 [TBL] [Abstract][Full Text] [Related]
20. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists. Cauli O; Morelli M Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]